Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD

Slides:

Advertisements

Similar presentations

Strict volume control normalizes hypertension in peritoneal dialysis patients Ali Ihsan Günal, MD, Soner Duman, MD, Mehmet Özkahya, MD, Hüseyin Töz, MD,

Advertisements

Volume 59, Issue 2, Pages (February 2001)

Renal Function Testing

Hemodialysis Vascular Access Creation in Patients Switching From Peritoneal Dialysis to Hemodialysis: A Population-Based Retrospective Cohort Ahmed A.

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

MyPlate for Healthy Eating With Chronic Kidney Disease (MyPlate Education for Patients With Chronic Kidney Disease Receiving Hemodialysis and Peritoneal.

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

This Month in AJKD American Journal of Kidney Diseases

Quiz page American Journal of Kidney Diseases

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Hung-Bin Tsai, MD, Chia-Ter Chao, MD

Evaluation of the Potential Living Kidney Donor

Differences in Use of Peritoneal Dialysis and Survival Among East Asian, Indo Asian, and White ESRD Patients in Canada Brenda R. Hemmelgarn, PhD, MD,

This Month in AJKD American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Volume 80, Issue 9, Pages (November 2011)

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

This Month in AJKD American Journal of Kidney Diseases

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Peritoneal dialysis in patients with dementia

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Body size and outcomes on peritoneal dialysis in the United States

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV Kevin C Abbott, MD,

Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome Masaru Nakayama, MD, Ritsuko Katafuchi, MD, Tetsuro.

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Intensive Hemodialysis and Potential Risks With Increasing Treatment

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States George A. Kaysen, MD, PhD, Kirsten.

Nutritional management of dialysis patients: Balancing among nutrient intake, dialysis dose, and nutritional status Toshiyuki Nakao, MD, Hiroshi Matsumoto,

Risk for Incident Renal Dialysis in a Managed Care Population

Racial disparities in kidney health: The puzzle to solve

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

The failure of breast cancer screening

Economic Burden of Incident Unplanned Starts on Peritoneal Dialysis in a High Specialty Health Care Facility in Mexico City Sergio O. Hdez Ordonez, MD,

Making Music American Journal of Kidney Diseases

Why measure serum albumin levels?

This Month in AJKD American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

The Use of Vaccines in Adult Patients With Renal Disease

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

In reply: American Journal of Kidney Diseases

Five years is a long time, especially if you're a dean

This Month in AJKD American Journal of Kidney Diseases

Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS

Supportive care for patients with renal disease: Time for action

American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Role of glucocorticoids in acidosis

Volume 59, Issue 2, Pages (February 2001)

Volume 61, Issue 2, Pages (February 2002)

This Month in AJKD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Serum Leptin and Epoetin Sensitivity

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Maristela Böhlke, PhD American Journal of Kidney Diseases

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

This Month in AJKD American Journal of Kidney Diseases

Presentation transcript:

Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD American Journal of Kidney Diseases Volume 36, Issue 6, Pages 1175-1182 (December 2000) DOI: 10.1053/ajkd.2000.19832 Copyright © 2000 National Kidney Foundation, Inc Terms and Conditions

Fig 1 Adjusted patient survival for all patients based on modality of therapy using an as-treated analysis with no modality × race interaction (RR for PD versus HD, 0.80; P = 0.21). American Journal of Kidney Diseases 2000 36, 1175-1182DOI: (10.1053/ajkd.2000.19832) Copyright © 2000 National Kidney Foundation, Inc Terms and Conditions

Fig 2 Adjusted patient survival for black patients based on modality of therapy using an as-treated analysis that includes a modality × race interaction (RR for PD versus HD, 0.69; P = 0.09). American Journal of Kidney Diseases 2000 36, 1175-1182DOI: (10.1053/ajkd.2000.19832) Copyright © 2000 National Kidney Foundation, Inc Terms and Conditions

Fig 3 Adjusted patient survival for white patients based on modality of therapy using an as-treated analysis that includes a modality × race interaction (RR for PD versus HD, 1.09; P = 0.79). American Journal of Kidney Diseases 2000 36, 1175-1182DOI: (10.1053/ajkd.2000.19832) Copyright © 2000 National Kidney Foundation, Inc Terms and Conditions